Volv Global
Curated by SignalAI-powered platform to detect undiagnosed rare and orphan diseases in population-scale data
Overview
AI-powered platform to detect undiagnosed rare and orphan diseases in population-scale data. The company utilizes AI methodology called inTrigue, which employs machine learning to identify undiagnosed rare and orphan diseases in large datasets like electronic health and claims records. The company's product assist innovators in the rare disease field by providing new insights that enrich disease understanding early in clinical development processes.
Key facts
- Founded
- 2017
- Headquarters
- Epalinges, Switzerland
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 5 products and services
- Sign up to view
Contact
- Phone
- Sign up to view